Adiposity, metabolites and endometrial cancer risk: Mendelian randomization and Observational analyses
View ORCID ProfileMatthew A Lee, Vanessa Y. Tan, Dimitri J Pournaras, Sabrina Wang, Laure Dossus, Marc J. Gunter, Kaitlin H. Wade, Laura J. Corbin, Nicholas J. Timpson
doi: https://doi.org/10.1101/2024.04.18.24305987
Matthew A Lee
1Medical Research Council (MRC) Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom
2Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom
3International Agency for Research on Cancer, World Health Organization, Lyon, France
Vanessa Y. Tan
1Medical Research Council (MRC) Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom
2Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom
Dimitri J Pournaras
4Department of Upper GI and Bariatric/Metabolic Surgery, North Bristol NHS Trust, Southmead Hospital, Bristol, UK
Sabrina Wang
3International Agency for Research on Cancer, World Health Organization, Lyon, France
Laure Dossus
3International Agency for Research on Cancer, World Health Organization, Lyon, France
Marc J. Gunter
3International Agency for Research on Cancer, World Health Organization, Lyon, France
5Cancer Epidemiology and Prevention Research Unit, School of Public Health, Imperial College London, United Kingdom
Kaitlin H. Wade
1Medical Research Council (MRC) Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom
2Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom
Laura J. Corbin
1Medical Research Council (MRC) Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom
2Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom
Nicholas J. Timpson
1Medical Research Council (MRC) Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom
2Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom
Article usage
Posted April 19, 2024.
Adiposity, metabolites and endometrial cancer risk: Mendelian randomization and Observational analyses
Matthew A Lee, Vanessa Y. Tan, Dimitri J Pournaras, Sabrina Wang, Laure Dossus, Marc J. Gunter, Kaitlin H. Wade, Laura J. Corbin, Nicholas J. Timpson
medRxiv 2024.04.18.24305987; doi: https://doi.org/10.1101/2024.04.18.24305987
Adiposity, metabolites and endometrial cancer risk: Mendelian randomization and Observational analyses
Matthew A Lee, Vanessa Y. Tan, Dimitri J Pournaras, Sabrina Wang, Laure Dossus, Marc J. Gunter, Kaitlin H. Wade, Laura J. Corbin, Nicholas J. Timpson
medRxiv 2024.04.18.24305987; doi: https://doi.org/10.1101/2024.04.18.24305987
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (708)
- Anesthesia (201)
- Cardiovascular Medicine (2936)
- Dermatology (249)
- Emergency Medicine (439)
- Epidemiology (12741)
- Forensic Medicine (12)
- Gastroenterology (828)
- Genetic and Genomic Medicine (4581)
- Geriatric Medicine (417)
- Health Economics (729)
- Health Informatics (2914)
- Health Policy (1069)
- Hematology (388)
- HIV/AIDS (924)
- Medical Education (425)
- Medical Ethics (115)
- Nephrology (468)
- Neurology (4348)
- Nursing (236)
- Nutrition (638)
- Oncology (2268)
- Ophthalmology (646)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (501)
- Pediatrics (1196)
- Primary Care Research (496)
- Public and Global Health (6934)
- Radiology and Imaging (1527)
- Respiratory Medicine (915)
- Rheumatology (437)
- Sports Medicine (385)
- Surgery (488)
- Toxicology (60)
- Transplantation (211)
- Urology (180)